Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study

Momar Diouf (1, 2) , Benoist Chibaudel (3, 4) , Thomas Filleron (5) , Christophe Tournigand (6) , Marine Hug de Larauze (7) , Marie-Line Garcia-Larnicol (3, 4) , Sarah Dumont (3, 4) , Christophe Louvet (8) , Nathalie Perez-Staub (3, 4) , Alexandra Hadengue (7) , Aimery de Gramont (3, 4) , Franck Bonnetain (1, 7)

1 Service d'Oncologie Médicale [CHRU Besançon]
2 Direction de la recherche clinique et de l'innovation [CHU Amiens]
3 CHU Saint-Antoine [AP-HP]
4 UPMC - Université Pierre et Marie Curie - Paris 6
5 Institut Claudius Regaud
6 Service d'Oncologie médicale [CHU Henri Mondor]
7 GERCOR - Cooperator Multidisciplinary Oncology Group
8 Service d'Oncologie Médicale [Montsouris]

Background: Health-related quality of life (QoL) has prognostic value in many cancers. A recent study found that the performance of prognostic systems for metastatic colorectal cancer (mCRC) were improvable. We evaluated the independent prognostic value of QoL for overall survival (OS) and its ability to improve two prognostic systems'performance (Köhne and GERCOR models) for patients with mCRC. Methods: The EQ-5D questionnaire was self-completed before randomization in the OPTIMOX1, a phase III trial comparing two strategies of FOLFOX chemotherapy which included 620 previously untreated mCRC patients recruited from January 2000 to June 2002 from 56 institutions in five countries. The improvement in models' performance (after addition of QoL) was studied with Harrell's C-index and the net reclassification improvement. Results: Of the 620 patients, 249 (40%) completed QoL datasets. The Köhne model could be improved by LDH, mobility and pain/discomfort; the C-index rose from 0.54 to 0.67. The associated NRI for 12-month death was 0.23 [0.05; 0.46]. Mobility and pain/discomfort could be added to the GERCOR model: the C-index varied from 0.63 to 0.68. The NRI for 12 months death was 0.35 [0.12; 0.44]. Conclusions: Mobility and pain dimensions of EQ5D are independent prognostic factors and could be useful for staging and treatment assignment of mCRC patients. Presented at the 2011 ASCO Annual Meeting (#3632).

Domaines: Médecine humaine et pathologie

Momar Diouf, Benoist Chibaudel, Thomas Filleron, Christophe Tournigand, Marine Hug de Larauze, et al.. Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study. Health and Quality of Life Outcomes, 2014, 12, pp.69. ⟨10.1186/1477-7525-12-69⟩. ⟨hal-01327781⟩